Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice.


Journal

Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637

Informations de publication

Date de publication:
04 2020
Historique:
received: 15 08 2019
revised: 08 12 2019
accepted: 24 01 2020
pubmed: 30 1 2020
medline: 11 11 2020
entrez: 30 1 2020
Statut: ppublish

Résumé

Persistent activation of the latent transcription factor STAT3 is observed in gastric tumor epithelial and immune cells and is associated with a poor patient prognosis. Although targeting STAT3-activating upstream kinases offers therapeutically viable targets with limited specificity, direct inhibition of STAT3 remains challenging. Here we provide functional evidence that myeloid-specific hematopoietic cell kinase (HCK) activity can drive STAT3-dependent epithelial tumor growth in mice and is associated with alternative macrophage activation alongside matrix remodeling and tumor cell invasion. Accordingly, genetic reduction of HCK expression in bone marrow-derived cells or systemic pharmacologic inhibition of HCK activity suppresses alternative macrophage polarization and epithelial STAT3 activation, and impairs tumor growth. These data validate HCK as a molecular target for the treatment of human solid tumors harboring excessive STAT3 activity.

Identifiants

pubmed: 31992566
pii: 2326-6066.CIR-19-0623
doi: 10.1158/2326-6066.CIR-19-0623
pmc: PMC8064588
mid: NIHMS1690732
doi:

Substances chimiques

Pyrimidines 0
Pyrroles 0
RK-20449 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
Stat3 protein, mouse 0
HCK protein, human EC 2.7.10.2
Hck protein, mouse EC 2.7.10.2
Proto-Oncogene Proteins c-hck EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

428-435

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI113272
Pays : United States

Informations de copyright

©2020 American Association for Cancer Research.

Références

Nat Rev Cancer. 2019 Feb;19(2):82-96
pubmed: 30578415
Sci Transl Med. 2013 Apr 17;5(181):181ra52
pubmed: 23596204
J Clin Invest. 2008 May;118(5):1727-38
pubmed: 18431520
Mol Cancer Ther. 2014 Feb;13(2):468-74
pubmed: 24398427
Prog Mol Biol Transl Sci. 2012;106:63-73
pubmed: 22340714
Exp Hematol. 1997 Dec;25(13):1367-77
pubmed: 9406996
Nat Med. 2005 Aug;11(8):845-52
pubmed: 16041381
Oncogene. 2014 Apr 17;33(16):2123-33
pubmed: 23644655
Cancer Cell. 2013 Aug 12;24(2):257-71
pubmed: 23948300
Mol Cell Biol. 2001 Dec;21(23):8068-81
pubmed: 11689697
Mol Cell Biol. 1987 Jun;7(6):2276-85
pubmed: 3453117
J Biol Methods. 2016 Jul 24;3(3):e49
pubmed: 31453214
Oncotarget. 2016 Aug 2;7(31):49322-49333
pubmed: 27384994
PLoS One. 2014 May 07;9(5):e95993
pubmed: 24804649
Oncotarget. 2015 Jun 30;6(18):15752-71
pubmed: 26087188
J Exp Med. 2002 Sep 2;196(5):589-604
pubmed: 12208875
Nat Rev Immunol. 2007 Jan;7(1):41-51
pubmed: 17186030
Carcinogenesis. 2009 Nov;30(11):1857-64
pubmed: 19734198
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Genesis. 2017 Apr;55(4):
pubmed: 28170160
Cancer Res. 1996 Oct 15;56(20):4625-9
pubmed: 8840975
J Gastroenterol Hepatol. 2016 Jul;31(7):1257-72
pubmed: 26809278
Blood. 2010 Feb 18;115(7):1444-52
pubmed: 19897576
J Immunol. 2011 Oct 1;187(7):3806-14
pubmed: 21880978
World J Gastroenterol. 2010 Nov 14;16(42):5380-7
pubmed: 21072904
Nat Med. 2005 Dec;11(12):1314-21
pubmed: 16288283
Pathol Int. 2012 Jul;62(7):477-84
pubmed: 22691185
Neoplasia. 2005 Jun;7(6):545-55
pubmed: 16036105
Genes Dev. 1994 Feb 15;8(4):387-98
pubmed: 8125254
Cancer Cell. 2017 Apr 10;31(4):563-575.e5
pubmed: 28399411
J Biol Chem. 2014 Mar 14;289(11):7897-906
pubmed: 24482227
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Ann Oncol. 2015 May;26(5):998-1005
pubmed: 25609248

Auteurs

Ashleigh R Poh (AR)

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Victoria, Australia.

Amy R Dwyer (AR)

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.

Moritz F Eissmann (MF)

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Victoria, Australia.

Ashwini L Chand (AL)

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Victoria, Australia.

David Baloyan (D)

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Victoria, Australia.

Louis Boon (L)

Bioceros BV, Utrecht, the Netherlands.

Michael W Murrey (MW)

School of Medicine and Pharmacology, The University of Western Australia, Western Australia, Australia.

Lachlan Whitehead (L)

The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Victoria, Australia.

Megan O'Brien (M)

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Victoria, Australia.

Clifford A Lowell (CA)

University of California San Francisco, San Francisco, California.

Tracy L Putoczki (TL)

The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Victoria, Australia.

Fiona J Pixley (FJ)

School of Medicine and Pharmacology, The University of Western Australia, Western Australia, Australia.

Robert J J O'Donoghue (RJJ)

Department of Pharmacology and Therapeutics, University of Melbourne, Victoria, Australia.

Matthias Ernst (M)

Olivia Newton-John Cancer Research Institute and La Trobe University School of Cancer Medicine, Victoria, Australia. Matthias.Ernst@ONJCRI.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH